Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Visualize Index Level and price together to reveal trend strength and timing. This overview helps traders align momentum with price moves.
28,655 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A major investor liquidated a sizable stake as the decking stock down 35% over the past year. This article breaks dow...
Aluminum equities trade higher as supply discipline tightens and demand from aerospace and packaging stays resilient....
Brad Reese, heir to the Reese’s legacy, alleges Hershey’s has shifted core ingredients in Reese’s cups. Hershey says ...
Starting with $1,000 doesn’t limit your ability to build lasting passive income. This guide presents two dependable d...
If you’ve got $4,000, deciding between Dogecoin and Solana can feel overwhelming. This guide breaks down real-world u...
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
MP Materials scored a powerful April rally, but the move wasn’t sparked by a single headline. This article digs into ...
Inside the Federal Reserve, a high-stakes power struggle quietly guides the cost of money. This tug-of-war influences...
A high-conviction bet on a Chinese logistics platform faced a sharp stock drop. This article explains why the fund wa...
Investing in AI stocks can feel like a fast-moving target. This article breaks down whether penguin solutions next st...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...